021-51111890
购物车（）
sales@molnova.cn
SLLK, Control Peptide for TSP1 Inhibitor(TFA)
CAS No. ——
SLLK, Control Peptide for TSP1 Inhibitor(TFA) ( —— )
产品货号. M30149 CAS No. ——
SLLK, Control Peptide for TSP1 Inhibitor (TFA) is a control peptide for LSKL, which is a Thrombospondin (TSP-1) inhibitor.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
生物学信息
-
产品名称SLLK, Control Peptide for TSP1 Inhibitor(TFA)
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述SLLK, Control Peptide for TSP1 Inhibitor (TFA) is a control peptide for LSKL, which is a Thrombospondin (TSP-1) inhibitor.
-
产品描述SLLK, Control Peptide for TSP1 Inhibitor (TFA) is a control peptide for LSKL, which is a Thrombospondin (TSP-1) inhibitor.(In Vivo):Akita mice treated with 30 mg/kg LSKL have significantly increased nephrin expression, greater than twofold, compared with renal lysates from either saline controls or SLLK-treated mice.TGF-β1 is significantly lower (0.10±0.01 pg/mL) in the plasma of mice receiving LSKL compared with that in plasma of mice receiving SLLK control peptide at day 42 (0.20±0.02 pg/mL; P=0.0001). MRNA expression is assessed in the suprarenal aortic lysates obtained from mice receiving SLLK and LSKL peptides.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number——
-
分子量573.6
-
分子式C23H42F3N5O8
-
纯度>98% (HPLC)
-
溶解度H2O : 135 mg/mL (235.36 mM; Need ultrasonic)
-
SMILES——
-
化学全称Sequence:Ser-Leu-Leu-Lys-NH2
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
Lu A, et al. Blockade of TSP1-dependent TGF-β activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy. Am J Pathol. 2011 Jun;178(6):2573-86.
产品手册
关联产品
-
4-Hydroxybenzamide
4-Hydroxybenzamide is a natural product from Berberis pruinosa.
-
Lenacapavir
Lenacapavir 是一种有效的 HIV 复制衣壳靶向抑制剂。 Lenacapavir 在 MT-4 细胞中显示出抗 HIV 活性，EC50 为 100 pM。
-
Ethionine
乙硫氨酸是一种抗代谢物和甲硫氨酸拮抗剂。它还产生肝脏肿瘤。
